Also known as a strawberry naevus, an infantile haemangioma is a proliferative benign tumour affecting the cutaneous blood vessels, in which the endothelial cells lining the vessels proliferate in an overgrowth manner. A haemangioma…
Read more
From 18th September 2020, all products containing bufexamac will be removed from the Australian Register of Therapeutic Goods (ARTG). This action follows an investigation by the Therapeutic Goods Administration (TGA), which concluded that the…
Read more
Product Notice HPS Pharmacies wish to give notice that Aspen Australia has identified a packaging issue for the following products: Product ARTG Marcain® 0.25% with adrenaline 1:400,000 20mL injection vial 125878 Marcain® 0.5% with adrenaline 1:200,000…
Read more
HPS Pharmacies wish to give notice that Pfizer Australia has discontinued both brands of tinidazole tablets as follows: Simplotan® Tablets Tinidazole 500mg ARTG 48964 Fasigyn® Tablets Tinidazole 500mg ARTG 48414 Tinidazole is a nitroimidazole antibiotic that…
Read more
Product Recall HPS Pharmacies wish to advise that Generic Health, in consultation with the Therapeutic Goods Administration (TGA), has given notice of a product recall for Pharmacy Action Antiseptic Cream as follows: Pharmacy Action Antiseptic Cream…
Read more
On the 1st of January 2020 abemaciclib became listed on the Pharmaceutical Benefits Scheme (PBS) for first-line treatment for non-premenopausal people newly diagnosed with hormone receptor positive, HER2-negative locally advanced or metastatic breast cancer,…
Read moreTreatment of Infantile Haemangioma (Sep. 25 2020)
Removal of Bufexamac Products (Sep. 18 2020)
Product Notice for Local Anaesthetics (Sep. 18 2020)
Discontinuation of Tinidazole (Sep. 15 2020)
Recall of Pharmacy Action Antiseptic Cream (Sep. 11 2020)
Abemaciclib for Breast Cancer (Sep. 11 2020)
Product Notice for Sinemet® Tablets (Sep. 10 2020)
Acalabrutinib on the PBS (Sep. 04 2020)
Availability of Tambocor® Ampoules (Sep. 01 2020)
Availability of Local Anaesthetic Products (Sep. 01 2020)
Availability of Intranasal Minirin® (Aug. 31 2020)
Availability of Sinemet® CR (Aug. 31 2020)
Primary Cutaneous T-cell Lymphoma (Aug. 28 2020)
Availability of DBL™ Magnesium Sulfate Ampoules (Aug. 24 2020)
Availability of Intal® and Intal Forte® (Aug. 24 2020)
Availability of Captopril (Aug. 24 2020)
Hydrochlorothiazide and Skin Cancer (Aug. 21 2020)
Availability of Chlorhexidine Pre-Op Wash (Aug. 21 2020)
Availability of Phenytoin Ampoules (Aug. 18 2020)
Availability of Suxamethonium (Aug. 18 2020)
Safety Advisory for Oxycodone Sandoz® (Aug. 14 2020)
Availability of Brevinor® and Norimin® (Aug. 14 2020)
Recall of Abstral® (Aug. 12 2020)
Gliflozins and Heart Failure (Aug. 12 2020)
Availability of Clexane® (Aug. 11 2020)
Availability of Healon GV® (Aug. 11 2020)
Zoster vaccine and immunosuppression (Aug. 07 2020)
Discontinuation of Fresofol® LCT (Aug. 03 2020)
Availability of Gastrogel® (Aug. 03 2020)
Availability of Local Anaesthetic Products (Aug. 03 2020)
Remdesivir – an emerging treatment for COVID-19 patients. (Jul. 31 2020)
Availability of Vancomycin Alphapharm (Jul. 27 2020)
Availability of Symbicort® Rapihaler® (Jul. 27 2020)
Semaglutide on the PBS (Jul. 24 2020)
Availability of Zoely® Tablets (Jul. 22 2020)
Availability of Minirin® Nasal Spray (Jul. 22 2020)
Safe Injection Practices (Jul. 17 2020)
Recall of Sodium Chloride Bags (Jul. 10 2020)
Updates to the PBS criteria for evolocumab (Jul. 09 2020)
Diabetes and Insulin (Jul. 02 2020)
Availability of Local Anaesthetic Products (Jul. 01 2020)
Availability of Suxamethonium (Jul. 01 2020)
Recall of Abstral® (Jul. 01 2020)
Discontinuation of Roferon-A® (Jun. 18 2020)
Hydroxychloroquine as triple therapy in COVID-19 patients (Jun. 16 2020)
Combination Inhaler for Mild Asthma (Jun. 10 2020)
Tocilizumab, COVID-19 and the cytokine storm (Jun. 03 2020)
Defect Correction for Tacrolimus Apotex (Jun. 02 2020)
Insulin Glargine on the PBS (May. 27 2020)
Availability of Marevan® (May. 22 2020)
Availability of Fresofol® (May. 21 2020)
Colchicine use in Acute Myocardial Infarction (May. 20 2020)
Discontinuation of Effient® (May. 20 2020)
Availability of Artane® (May. 19 2020)
Availability of Pulmicort® & Symbicort® Turbuhalers® (May. 18 2020)
2020 HPS Lecture Series Programme (May. 15 2020)
Availability of Metformin (May. 14 2020)
PBS Changes for Common Antibiotics (May. 13 2020)
Changes to Opioid PBS Listings (May. 06 2020)
Discontinuation of Isuprel™ (Apr. 29 2020)
Neuraminidase Inhibitors for Influenza (Apr. 29 2020)
Availability of Local Anaesthetic Products (Apr. 28 2020)
Discontinuation of Asasantin® SR and Persantin® SR (Apr. 22 2020)
Availability of Metronidazole (Apr. 22 2020)
Coronavirus Disease (Apr. 22 2020)
Availability of Cisatracurium (Apr. 20 2020)
Availability of Aminophylline Ampoules (Apr. 17 2020)
Availability of Dobutamine Injection (Apr. 17 2020)
National COVID-19 Guidelines (Apr. 16 2020)
Risk of Viral Transmission with Nebulised Medication Delivery (Apr. 09 2020)
Availability of Levothyroxine (Apr. 09 2020)
Availability of Suxamethonium Ampoules (Apr. 09 2020)
Availability of Ipratropium Nebules (Apr. 07 2020)
Availability of Aminophylline Ampoules (Apr. 07 2020)
Discontinuation of Nardil® (Apr. 06 2020)
Availability of Gentamicin (Apr. 02 2020)
Prescribing Restrictions for Hydroxychloroquine (Apr. 02 2020)
Availability of Local Anaesthetic Products (Apr. 01 2020)
COVID-19 Summary of Published Information (Mar. 26 2020)
Availability of Adrenaline (Epinephrine) (Mar. 25 2020)
Defect correction for Palexia® SR 100mg (Mar. 24 2020)
Update on Influenza Vaccines (Mar. 19 2020)
Availability of Quinapril (Mar. 18 2020)
Availability of Firmagon® (Mar. 16 2020)
New PBS-listing for Atezolizumab in treatment of extensive-stage small cell lung cancer (Mar. 12 2020)
Availability of Lubricating Eye Ointments (Mar. 06 2020)
Generic Tiotropium Capsules (Mar. 05 2020)
Availability of Antabuse® (Mar. 05 2020)
Availability of Nifedipine (Mar. 04 2020)
Availability of Hydrocortisone Tablets (Mar. 03 2020)
Availability of Tilade® (Mar. 03 2020)
Availability of Local Anaesthetic Products (Mar. 02 2020)
Xerostomia (Feb. 27 2020)
Availability of Glucose Intravenous Infusion (Feb. 26 2020)
Availability of Ephedrine Hydrochloride (Feb. 26 2020)
Availability of OsmoLax® (Feb. 26 2020)
Availability of Famotidine (Feb. 26 2020)
Availability of BenPen™ (Feb. 21 2020)
Availability of Carbimazole (Feb. 21 2020)
Availability of Calcium Gluconate Gel (Feb. 21 2020)
Availability of Pindolol (Feb. 21 2020)
Availability of Bleomycin Vials (Feb. 21 2020)
Non-Steroidal Topical Therapy for Dermatitis (Feb. 20 2020)
Availability of Prazosin (Feb. 20 2020)
Availability of Phenoxymethylpenicillin (Feb. 20 2020)
Availability of Dantrolene (Feb. 20 2020)
Availability of Minipress® (Feb. 20 2020)
Availability of Verapamil Tablets (Feb. 19 2020)
Availability of Carafate® Tablets (Feb. 19 2020)
Availability of Pneumovax® 23 (Feb. 18 2020)
Availability of Span-K® Tablets (Feb. 17 2020)
Availability of Irinotecan (Feb. 17 2020)
Defect correction for Palexia® SR 100mg (Feb. 14 2020)
Availability of Haemorol™ (Feb. 14 2020)
Availability of Primacin® (Feb. 14 2020)
Availability of EpiPen® Jr. (Feb. 14 2020)
Monoclonal Antibodies for Migraine (Feb. 13 2020)
Availability of Amoxicillin & Clavulanic Acid Suspension (Feb. 12 2020)
Availability of Emollient Ointment Sterile (Feb. 11 2020)
Availability of Hydroxocobalamin Ampoules (Feb. 11 2020)
Availability of Fleet® Ready-to-Use Enema (Feb. 07 2020)
Availability of Gentamicin Ampoules (Feb. 07 2020)
Availability of Hand Sanitisers (Feb. 07 2020)
Availability of Ciprofloxacin IV (Feb. 07 2020)
Updated PBS-listing for Pembrolizumab in treatment of metastatic non-small cell lung cancer (Feb. 07 2020)
Availability of Zyban® SR Tablets (Feb. 06 2020)
Availability of DBL™ Rocuronium Bromide Vials (Feb. 05 2020)
Availability of Gastrogel Antacid® Oral Suspension (Feb. 05 2020)
Availability of Integrilin® (Feb. 05 2020)
Availability of Tamoxifen Tablets (Feb. 04 2020)
Availability of Ferro-Grad C® Tablets (Feb. 04 2020)
Availability of Minims® Phenylephrine Eye Drops (Feb. 04 2020)
Availability of Panadol® Suppositories (Feb. 04 2020)
Discontinuation of Zantac® Effervescent (Feb. 03 2020)
Availability of Nitrostat® Tablets (Jan. 31 2020)
Availability of Isoprenaline Ampoules (Jan. 30 2020)
Appearance Change for Temazepam Tablets (Jan. 30 2020)
Changes to Neural Connector Devices (Jan. 30 2020)
Availability of Pethidine (Jan. 24 2020)
Updated Oral and Dental Guidelines (Jan. 24 2020)
Availability of Minims® Phenylephrine Eye Drops (Jan. 23 2020)
Venetoclax (Jan. 16 2020)
New Contraindications for Glaucoma Medication (Jan. 10 2020)
Biosimilars in Oncology (Jan. 03 2020)
Ceftazidime with Avibactam (Dec. 27 2019)
Availability of Sodium Bicarbonate Vials (Dec. 20 2019)
Availability of Local Anaesthetic Products (Dec. 20 2019)
Availability of Hyalase® (Dec. 20 2019)
Availability of Phenelzine (Dec. 20 2019)
Availability of Famotidine (Dec. 19 2019)
Encorafenib, Binimetinib and Cetuximab Triplet Therapy in BRAF V600E- Mutant Metastatic Colorectal Cancer (Dec. 17 2019)
Notice For EpiPen® Jr. (Dec. 17 2019)
Teduglutide for Short Bowel Syndrome (Dec. 13 2019)
Availability of Kenacort®-A 40 (Dec. 10 2019)
The Role of Somatostatin Analogues in the Management of Gastroenteropancreatic Neuroendocrine Tumours (Dec. 06 2019)
Availability Of Heparin (Dec. 04 2019)
Availability of Local Anaesthetic Products (Dec. 02 2019)
Neratinib for Breast Cancer (Nov. 29 2019)
Availability of Marcain with Fentanyl (Nov. 22 2019)
Prescription Opioid Changes (Nov. 22 2019)
Availability Of Nizatidine Capsules (Nov. 15 2019)
Antibiotic Awareness Week (Nov. 15 2019)
Availability of Nizatidine Capsules (Nov. 14 2019)
Diabetes Medications in the Peri-Operative Period (Nov. 08 2019)
Buprenorphine Depot Injections (Nov. 01 2019)
Availability of Cyclizine Ampoules (Oct. 31 2019)
Product Notice for Clexane® Syringes (Oct. 29 2019)
Availability of Cefalotin (Oct. 29 2019)
Availability of Gentamicin (Oct. 28 2019)
Availability of Docetaxel (Oct. 25 2019)
Availability of Tranylcypromine (Oct. 25 2019)
Availability of Cefalotin (Oct. 25 2019)
Lamotrigine Dose Escalation (Oct. 25 2019)
Availability of Kenacort®-A 40 (Oct. 24 2019)
New Warning for Febuxostat (Oct. 18 2019)
Availability of OncoTICE® (Oct. 16 2019)
Wilson Disease (Oct. 11 2019)
Availability of Tranylcypromine (Oct. 11 2019)
Discontinuation of Morphine Tartrate (Oct. 11 2019)
Availability of Azithromycin Vials (Oct. 07 2019)
Recall of Ranitidine Products (Oct. 07 2019)
Naloxone Nasal Spray (Oct. 04 2019)
Availability of Heparin Sodium (Oct. 03 2019)
Zantac® Products (Oct. 02 2019)
Ranitidine Products (Oct. 02 2019)
Parkinson’s Disease and Hospitalisation (Sep. 27 2019)
Availability of Local Anaesthetic Products (Sep. 23 2019)
Product Notice for Metaraminol Juno Syringes (Sep. 23 2019)
Ranitidine Products (Sep. 23 2019)
Anticoagulants in Antiphospholipid Syndrome (Sep. 20 2019)
Product Notice for Metaraminol Juno Pre-Filled Syringes (Sep. 19 2019)
Safety Alert for Ranitidine (Sep. 18 2019)
Availability of Span-K® Tablets (Sep. 17 2019)
Understanding Clinical Trials (Sep. 13 2019)
Local Anaesthetics for Oromucosal Use (Sep. 06 2019)
Availability of Midazolam (Sep. 03 2019)
Availability of Adrenaline (Sep. 03 2019)
Availability of Sodium Citrate Dihydrate (Sep. 03 2019)
Availability of Tranylcypromine (Aug. 30 2019)
Availability of Sulfamethoxazole + Trimethoprim Ampoules (Aug. 30 2019)
Short-Course Oxycodone Packs (Aug. 30 2019)
Availability of Morphine Tartrate (Aug. 27 2019)
Availability of Local Anaesthetic Products (Aug. 26 2019)
Rufinamide for Lennox-Gastaut Syndrome (Aug. 23 2019)
Availability of Heparin (Aug. 19 2019)
Tafenoquine: A Novel Anti-Malarial (Aug. 16 2019)
Discontinuation of Timoptol-XE® 0.25% (Aug. 14 2019)
New Treatment for Carcinoid Syndrome (Aug. 09 2019)
Quarantine Update for Baxter Infusion Bags (Aug. 06 2019)
Product Notice for Juno Pre-Filled Syringes (Aug. 06 2019)
Discontinuation of Pfizer Antibiotics (Aug. 06 2019)
Medicinal Marijuana? (Aug. 02 2019)
Availability of BenPen (Aug. 01 2019)
Availability of Nicorandil (Aug. 01 2019)
Availability of Local Anaesthetic Products (Aug. 01 2019)
Product Defect Correction for Endone® (Jul. 31 2019)
Quarantine for Endone® (Jul. 29 2019)
PBS Changes for Pembrolizumab Listing (Jul. 26 2019)
Availability of Ventolin® Syrup (Jul. 24 2019)
Discontinuation of Gelclair® Oral Gel (Jul. 24 2019)
Primary Prevention: a Low-Dose Aspirin Story (Jul. 19 2019)
Discontinuation of Calsource® Ca1000 (Jul. 16 2019)
Discontinuation of Saizen® 3mg (Jul. 16 2019)
Availability of Azithromycin (Jul. 16 2019)
Baxter Potassium Chloride Intravenous Infusion Bag (Jul. 15 2019)
Updated Results for Pembrolizumab in treatment of metastatic non-small cell lung cancer (Jul. 12 2019)
Hand-Foot Syndrome (Jul. 08 2019)
Availability of Folinic Acid Vials (Jul. 03 2019)
Discontinuation of Keytruda® 50mg (Jul. 03 2019)
Availability of OncoTICE® (Jul. 03 2019)
Availability of Miochol-E (Jul. 02 2019)
Availability of Pethidine (Jul. 02 2019)
Palbociclib added to the Pharmaceutical Benefits Scheme (Jun. 28 2019)
Low Dose Methotrexate for Rheumatoid Arthritis (Jun. 21 2019)
Availability of Heparin (Jun. 19 2019)
Availability of Local Anaesthetic Products (Jun. 19 2019)
Availability of Fentanyl Ampoules (Jun. 17 2019)
Faster-Acting Insulin Aspart (Jun. 14 2019)
Availability of Local Anaesthetic Products (Jun. 13 2019)
Introduction to the storage of medications in a private hospital setting (Jun. 07 2019)
Availability of Zyban® SR (Jun. 06 2019)
Availability of Heparin (Jun. 05 2019)
Availability of Local Anaesthetic Products (Jun. 03 2019)
Availability of Septrin® Oral Liquid (May. 31 2019)
Packaging Update for Laceraine® (May. 31 2019)
Alemtuzumab Safety Review (May. 31 2019)
Safety Alert for Adrenaline (May. 30 2019)
Availability of Ventolin® Ampoules (May. 24 2019)
Lactulose for Hepatic Encephalopathy (May. 24 2019)
Recall for Curam Duo (May. 22 2019)
Availability of Pemetrexed (May. 17 2019)
Safinamide for Parkinson’s Disease (May. 17 2019)
Availability of Irbesartan (May. 16 2019)
Availability of Flucloxacillin (May. 16 2019)
Availability of Metoclopramide Ampoules (May. 14 2019)
Proton Pump Inhibitor Restrictions (May. 10 2019)
Availability of Priorix® and Priorix-Tetra® (May. 09 2019)
Availability of Fentanyl Ampoules (May. 09 2019)
Availability of Minims® Eye Drops (May. 09 2019)
Updated Recommendations for Measles Vaccination (May. 03 2019)
Availability of Fentanyl Ampoules (Apr. 26 2019)
Prevention of Recurrent Clostridium difficile Infection (Apr. 25 2019)
Product Recall for Myxazole® (Apr. 24 2019)
Availability of Bleomycin Vials (Apr. 23 2019)
Availability of Local Anaesthetic Products (Apr. 23 2019)
New High-Strength Insulin (Apr. 18 2019)
Availability of Oxycodone Ampoules (Apr. 16 2019)
Updates to the Australian Asthma Handbook (Apr. 12 2019)
Availability of Azithromycin Vial (Apr. 11 2019)
Tofacitinib Safety Issue (Apr. 05 2019)
Availability of Local Anaesthetic Products (Mar. 29 2019)
Availability of Somac Granules (Mar. 29 2019)
Heparins (Mar. 29 2019)
New Medication for Weight Management (Mar. 22 2019)
Safety and Quality Standards for Mental Health (Mar. 15 2019)
Packaging Change for Bicillin L-A (Mar. 08 2019)
Carbimazole Safety Issues (Mar. 08 2019)
Availability of Local Anaesthetic Products (Mar. 04 2019)
Potentially Harmful Medication Use in the Elderly (Mar. 01 2019)
Updated Recall Procedures (Feb. 22 2019)
Availability of Dicloxacillin (Feb. 21 2019)
Animal-Assisted Therapy for Dementia (Feb. 15 2019)
Product Defect Correction for Jurnista® (Feb. 14 2019)
Appropriate Use of Promethazine (Feb. 08 2019)
Availability of Sulfamethoxazole + Trimethoprim (Feb. 04 2019)
Availability of Local Anaesthetic Products (Feb. 01 2019)
Augmented Renal Clearance (Feb. 01 2019)
Recall for Empovir® Vials (Jan. 30 2019)
New Contraindication for Doxycycline (Jan. 25 2019)
Discontinuation of Emend® Capsules (Jan. 24 2019)
Availability of Chlorvescent® Tablets (Jan. 24 2019)
Availability of Citracal Tablets (Jan. 18 2019)
Biofilms (Jan. 18 2019)
Availability of Pantoprazole Vials (Jan. 11 2019)
Ertugliflozin for Type 2 Diabetes (Jan. 11 2019)
Medications and Sun Exposure (Jan. 04 2019)
Availability of Sinemet CR® (Jan. 02 2019)
Recall for Milrinone (Jan. 02 2019)
Monoclonal Antibody for Migraines (Dec. 28 2018)
Recall for Irebesartan HCT Sandoz (Dec. 21 2018)
Abatacept Therapy (Dec. 21 2018)
Recall for APO-Valsartan (Dec. 18 2018)
Availability of Citracal Tablets (Dec. 18 2018)
Availability of Metronidazole for Injection (Dec. 17 2018)
Pholcodine and Anaphylaxis (Dec. 14 2018)
Trifluridine / Tipiracil (Lonsurf®) (Dec. 07 2018)
Minimising Harms Associated with Pregabalin (Nov. 30 2018)
Recall for Dilart® and Dilart® HCT Tablets (Nov. 26 2018)
Deprescribing (Nov. 23 2018)
Neuromuscular Blocking Agents (Nov. 16 2018)
Suboxone® Film 2mg/0.5mg (Nov. 12 2018)
Availability of Moxifloxacin Tablets (Nov. 09 2018)
Herpes Zoster and Postherpetic Neuralgia Management (Nov. 08 2018)
Pembrolizumab Listing Extended (Nov. 02 2018)
Electronic Health Records (Oct. 26 2018)
New Hope for Cystic Fibrosis (Oct. 19 2018)
Management of Immunotherapy-induced Cytokine Release Syndrome (Oct. 12 2018)
The Black Triangle Scheme (Oct. 05 2018)
Chemistry and Medication (Sep. 28 2018)
Reporting of Medicine Shortages (Sep. 21 2018)
Availability of Ergometrine Ampoules (Sep. 19 2018)
Labelling Issue for Zincaps (Sep. 19 2018)
Antifungal Prophylaxis in Haematology: A Review of the Guidelines (Sep. 14 2018)
Availability of Fentanyl Ampoules (Sep. 07 2018)
Appropriate use of slow-release opioids (Sep. 07 2018)
2019 HPS Lecture Series Programme (Sep. 06 2018)
Availability of Tracrium® Injection (Aug. 31 2018)
The Importance of Medicines Reconciliation and the Medication Management Plan (Aug. 31 2018)
Drug Recall for Clopine® Suspension (Aug. 29 2018)
Indications Extended for Ixekizumab (Aug. 24 2018)
Prescription Drug Misuse and Abuse (Aug. 17 2018)
Ryzodeg®: A New Mixed Insulin (Aug. 10 2018)
Availability Update of Heparin Sodium (Aug. 07 2018)
Product Notification for Dilantin® Capsules (Aug. 06 2018)
Oral Mesalazine Formulations (Aug. 03 2018)
Ribociclib for Breast Cancer (Jul. 27 2018)
Quarantine for Linezolid MYX™ Injection (Jul. 23 2018)
Tumour Lysis Syndrome: An Oncological Emergency (Jul. 20 2018)
Glucagon-like Peptide-1 Analogues (Jul. 13 2018)
Discontinuation of Sotacor® Ampoules (Jul. 06 2018)
StrataXRT® in Radiation-induced Skin Reactions (Jul. 06 2018)
Triple Therapy for Chronic Obstructive Pulmonary Disease (Jun. 29 2018)
Availability of Span-K® Slow Release Tablets (Jun. 22 2018)
Drug Recall for DBL™ Metronidazole Intravenous Infusion (Jun. 22 2018)
Medication Use in Paediatric Populations (Jun. 22 2018)
Availability of Edronax® Tablets (Jun. 20 2018)
Possible Risk of Birth Defects with Dolutegravir (Jun. 15 2018)
Discontinuation of ReoPro® (Jun. 12 2018)
Capsule Confusion: Pills That Should Not Be Swallowed (Jun. 08 2018)
Drug Recall of Infacol® Wind Drops (Jun. 06 2018)
Product Alert for DBL™ Metronidazole Intravenous Infusion (Jun. 06 2018)
Product Alert for Valpam® 5mg Tablets (Jun. 05 2018)
Thrombolytic Therapy in Ischaemic Stroke (Jun. 01 2018)
Availability of Glyceryl Trinitrate Ampoules (May. 29 2018)
Availability of Promethazine Ampoules (May. 28 2018)
Precaution for Ferinject® Vials (May. 28 2018)
Hereditary Angioedema (May. 25 2018)
Availability of Pancuronium (May. 22 2018)
Suspected Drug-Herb Interaction Raises INR (May. 18 2018)
A Comparison of Antiemetics Used in Chemotherapy-Induced Nausea and Vomiting (CINV) (May. 16 2018)
Availability of Dantrium® Capsules (May. 10 2018)
Daratumumab for Multiple Myeloma (May. 04 2018)
Availability of Local Anaesthetic Products (May. 03 2018)
Reducing HIV Transmission (Apr. 27 2018)
Availability Update of Premarin® Tablets (Apr. 23 2018)
Availability of Edronax® Tablets (Apr. 20 2018)
Updated PBS Listings for Type 2 Diabetes (Apr. 19 2018)
Availability of Morphine Ampoules (Apr. 16 2018)
Chemotherapy-Induced Nausea and Vomiting (Apr. 13 2018)
Subcutaneous Methotrexate (Apr. 06 2018)
Availability of Ircal® and Refresh® Eye Ointments (Apr. 06 2018)
Availability of Heparin Sodium (Apr. 04 2018)
Management of Breakthrough Seizures (Mar. 29 2018)
Increasing Antibiotic Resistance in E. coli (Mar. 23 2018)
Product Notification for Clopine® Suspension (Update) (Mar. 23 2018)
Drug Recall of APO-Zoledronic Acid (Mar. 23 2018)
Update for the 2018 Influenza Season (Mar. 16 2018)
Drug Discontinuation of Zinbryta® (Mar. 15 2018)
Treatment of Gastro-Oesophageal Reflux in Infants (Mar. 09 2018)
Osteomyelitis (Mar. 02 2018)
Availability of Local Anaesthetic Products (Mar. 01 2018)
Availability of Minidiab® Tablets (Mar. 01 2018)
Vertebral Fracture Risk Following Cessation of Denosumab (Feb. 23 2018)
Availability of Premarin® Tablets (Feb. 23 2018)
Product Notification for Clopine® Suspension (Feb. 20 2018)
Availability of Nimodipine Tablets (Feb. 19 2018)
Antihypertensives in Review (Feb. 16 2018)
Atypical Diabetic Ketoacidosis and SGLT2 Inhibitors (Feb. 09 2018)
Availability of Metoprolol for Injection (Feb. 05 2018)
Contact Dermatitis (Feb. 02 2018)
Availability of Imigran® Nasal Spray (Feb. 01 2018)
Carfilzomib on the PBS (Jan. 25 2018)
Product Notification for Velcade® (Jan. 24 2018)
Lonsurf® (Jan. 19 2018)
Drug Recall of APO-Metformin XR 1000mg (Jan. 18 2018)
Availability of Xylocaine® Ampoules (Update) (Jan. 17 2018)
Safety Precaution for Midazolam Ampoules (Jan. 15 2018)
Vorinostat for Cutaneous Tcell Lymphoma (Jan. 11 2018)
Metronidazole (DBL) 500mg Infusion Bag 100ml x10 (Jan. 09 2018)
Improved Protection Against Human Papillomavirus (Jan. 05 2018)
Increasing the Success of a Quit Attempt (Dec. 28 2017)
2017 Revised Classification of Seizures (Dec. 22 2017)
Availability of Xylocaine® Ampoules (Dec. 19 2017)
The Benefits of Statin Therapy (Dec. 14 2017)
2018 HPS Lecture Series Programme (Dec. 13 2017)
Osteoporosis Management: New Emerging Side Effects (Dec. 07 2017)
Brexpiprazole for the Treatment of Schizophrenia (Nov. 30 2017)
Iron Deficiency Anaemia (Nov. 23 2017)
Drug Recall Update of APOPerindopril Arginine (Nov. 22 2017)
A Surprising Potential Benefit of Thiazolidinedione Therapy (Nov. 16 2017)
Drug Recall Update of APOPerindopril Arginine (Nov. 15 2017)
A Literature Review of the Safety and Efficacy of New Oral Anticoagulants (Nov. 09 2017)
Drug Recall of APOPerindopril Arginine (Nov. 09 2017)
Availability of Methotrexate Vials (Nov. 08 2017)
Recall of Midazolam Apotex 5mg/1ml Ampoules (Nov. 07 2017)
Ibrutinib to be PBS Listed (Nov. 02 2017)
Availability of Methotrexate Vials (Oct. 30 2017)
Treatment of Hot Flushes in Menopause (Oct. 26 2017)
Silodosin for Benign Prostatic Hyperplasia (Oct. 19 2017)
Drug Recall of Dimetapp® Cough Cold & Flu Daytime/Nighttime Liquid Capsules (Oct. 17 2017)
Availability of DBL™ Rocuronium Vials (Oct. 16 2017)
The role of Prazosin in the Treatment of Post-Traumatic Stress Disorder-Related Nightmares (Oct. 12 2017)
Recall of Midazolam Apotex 5mg/5ml Ampoules (Oct. 11 2017)
Availability of Pfizer Gentamicin Ampoules (Oct. 09 2017)
Interaction Update for Sodium Polystyrene Sulfonate (Oct. 05 2017)
Recall of Pfizer Gentamicin Injection (Oct. 05 2017)
Drug Recall of Lucrin® Depot Paediatric Injection (Oct. 02 2017)
Vortioxetine (Brintellix®) (Sep. 28 2017)
Thunderstorm Asthma (Sep. 21 2017)
Availability of Diprosone® OV Ointment (Sep. 21 2017)
Drug Recall of LaxSachets® (Sep. 21 2017)
Availability of PiperTaz® Sandoz Injection (Sep. 20 2017)
Suvorexant (Belsomra®) (Sep. 14 2017)
Availability of DBL™ Vinblastine Vials (Sep. 11 2017)
Packaging Advisory for Curam® Duo Forte (Sep. 11 2017)
The Efficacy of Perampanel (Sep. 08 2017)
Availability of Hepatitis B Vaccines (Sep. 07 2017)
Hormone Replacement Therapy and Menopause (Aug. 31 2017)
New Option for Melanoma (Aug. 24 2017)
Pfizer Lignocaine 2% Gel Syringe (Aug. 24 2017)
Availability of Isuprel™ (Aug. 22 2017)
How to Take a Best Possible Medication History (Aug. 17 2017)
Recall for Product Correction of Heparin Ampoules (Aug. 13 2017)
Epclusa® – Pangenotypic Therapy for Hepatitis C (Aug. 10 2017)
Safety Alert of Heparin 5000 IU/5ml Ampoules (Aug. 10 2017)
Availability of Emend® 165mg Capsules (Aug. 09 2017)
Treatment of Insomnia (Aug. 03 2017)
Neonatal Caffeine Therapy (Jul. 27 2017)
International Harmonisation of Ingredient Names (Jul. 20 2017)
Availability of Fucidin® Tablets (Jul. 20 2017)
Availability of Vecure® Vials (Jul. 16 2017)
New Indication for Eribulin (Jul. 13 2017)
Medication Name Changes (Jul. 11 2017)
Availability of Isuprel™ (Jul. 10 2017)
Causes of Global Medicines Shortage (Jul. 06 2017)
Update on NSAID Safety (Jun. 29 2017)
Biosimilar Infliximab (Jun. 22 2017)
Nanoliposomal Irinotecan (Jun. 15 2017)
Availability of Heparin Ampoules (Jun. 14 2017)
Availability of Fentanyl Ampoules (Jun. 14 2017)
Availability of Hydromorphone Oral Liquid (Jun. 13 2017)
Valpam® 5mg Tablets (Jun. 12 2017)
Recall of Amlodipine Sandoz® 5mg Tablets (Jun. 12 2017)
Splitting Tablets – Is It Safe? (Jun. 08 2017)
Availability of Dilaudid® Oral Liquid (Jun. 06 2017)
Longacting Paliperidone Injection (Jun. 01 2017)
Availability of Fentanyl Ampoules (Jun. 01 2017)
Availability of Norfloxacin Tablets (Jun. 01 2017)
Recall of Stemetil® 5mg Tablets (May. 31 2017)
Pantoprazole 20mg Tablets (May. 30 2017)
Recall of Valium® 5mg Tablets (diazepam) (May. 28 2017)
Pantoprazole 40mg Tablets (May. 28 2017)
Combination Eye Drop to Control Intraocular Pressure (May. 26 2017)
Tofacitinib: A New Diseasemodifying Antirheumatic Drug (May. 18 2017)
Availability of Tinidazole Tablets (May. 18 2017)
Bydureon® (exenatide) (May. 11 2017)
Duavive® – Progestogenfree Menopausal Hormone Therapy (May. 04 2017)
Recall of Abilify Maintena® (Aripiprazole) (May. 04 2017)
Availability of Antabuse® Effervescent Tablets (Apr. 30 2017)
Management of Psoriasis (Apr. 27 2017)
Availability of Pipertaz Sandoz® (Apr. 25 2017)
Discontinuation of Dilaudid®– HP 50mg/5mL Ampoules (Apr. 20 2017)
Entyvio® (vedolizumab) (Apr. 20 2017)
Recall for Product Correction of SpanK® Tablets, Bottle (Apr. 18 2017)
Availability of Sofradex® and Otodex® Ear Drops (Apr. 17 2017)
Grains: Friends or Foes? (Apr. 12 2017)
Availability of Painstop® (Apr. 11 2017)
Availability of Metronidazole for Injection (Apr. 11 2017)
Availability of Dantrium® 20mg Vials (Apr. 11 2017)
Mirabegron for Overactive Bladder (Apr. 06 2017)
Availability of Nimenrix® Vaccine (Apr. 06 2017)
Antimicrobial Stewardship and Antibiotic Awareness Week at The Mater Hospital (Mar. 30 2017)
PBS Changes to Alprazolam (Mar. 23 2017)
Availability of Dantrium® 20mg Vials (Mar. 23 2017)
Availability of Prostin® E2 Vaginal Gel 2mg (Mar. 23 2017)
Recall of EpiPen® AutoInjector (adrenaline 300mcg) (Mar. 19 2017)
Clostridium Difficile Infections (Mar. 16 2017)
Recall of Mycophenolate Sandoz 250mg Capsules (Mar. 15 2017)
Availability of Antabuse® Effervescent Tablets (Mar. 15 2017)
Acute Management of Seizures (Mar. 09 2017)
Updates to Medicinal Cannabis Legislation (Mar. 02 2017)
Availability of Metronidazole Tablets (Feb. 26 2017)
Increased Notification of Meningococcal W Disease (Feb. 23 2017)
Availability of Norfloxacin Tablets (Feb. 20 2017)
Milnacipran Hydrochloride for Fibromyalgia (Feb. 16 2017)
Availability of Metaraminol Ampoules (Feb. 15 2017)
Olaparib Achieves PBS Approval (Feb. 09 2017)
Safety Advisory Update for Glyceryl Trinitrate Tablets (Feb. 09 2017)
Availability of Azithromycin for Injection (Feb. 07 2017)
Recall of Meropenem Kabi Vials (Feb. 07 2017)
Availability of Metronidazole Vials (Feb. 05 2017)
Topical Corticosteroids (Feb. 02 2017)
Risk of Gastroenteritis with PPI Use (Jan. 26 2017)
Availability of Pitressin® Vials (Jan. 26 2017)
Availability of Vancomycin Vials (Jan. 24 2017)
Availability of Dexamethasone Ampoules (Jan. 23 2017)
Managing Asthma During Pregnancy and Lactation (Jan. 19 2017)
Riociguat for Pulmonary Hypertension (Jan. 12 2017)
Symbicort Preparations: Are They the Same? (Jan. 05 2017)
Recall of Mirena® levonorgestrel 52mg intrauterine drug delivery system (Jan. 05 2017)
Updated Precautions for Direct Acting Antivirals (Dec. 29 2016)
2017 HPS Lecture Series Programme (Dec. 28 2016)
Availability of Precedex™ Vials (Dec. 27 2016)
Pharmacological treatment of clozapine-induced sialorrhoea (Dec. 22 2016)
Photodynamic Therapy for Actinic Keratosis (Dec. 15 2016)
Availability of Cyklokapron® Tablets (Dec. 15 2016)
Availability of Metronidazole Tablets (Dec. 14 2016)
Classifying Medications in Pregnancy (Dec. 08 2016)
Availability of Parenteral Antibiotics (Dec. 07 2016)
Discontinuation of ImmuCyst Vials (Dec. 07 2016)
Availability of Indometacin Capsules (Dec. 07 2016)
Availability of Indocid® (indometacin) Suppositories (Dec. 07 2016)
Recall of Dilantin Capsules and Tablets (Dec. 05 2016)
Subcutaneous Herceptin (trastuzumab) (Dec. 01 2016)
Real-World Evidence in Patients Treated with Rivaroxaban for Stroke Prevention in Atrial Fibrillation (Nov. 24 2016)
Availability of Atracurium Ampoules (Nov. 22 2016)
Availability Update of Remifentanil (Nov. 21 2016)
A New Therapy for Severe Asthma (Nov. 17 2016)
Availability of Norfloxacin Tablets (Nov. 16 2016)
Avoidable Causes of Hospital Admissions (Nov. 10 2016)
Availability of Marcaine® with Fentanyl (bupivacaine and fentanyl) Vials (Nov. 07 2016)
Shingles Vaccine Available on the NIP (Nov. 03 2016)
Recall of Atropine Injection BP (Oct. 30 2016)
Neuroleptic Malignant Syndrome: a rare but potentially fatal phenomenon (Oct. 27 2016)
Availability of Indocid® (indometacin) Suppositories (Oct. 25 2016)
Updated European Society of Cardiology Treatment Guidelines for the Management of Atrial Fibrillation (Oct. 20 2016)
Entresto® – A Combination of Sacubitril and Valsartan for Heart Failure (Oct. 13 2016)
Brivaracetam for Partial Onset Seizures (Oct. 06 2016)
Prevention of a Rare and Devastating Brain Infection (Sep. 29 2016)
Recall of Fludarabine Ebewe® Vials (fludarabine) (Sep. 28 2016)
Availability of Ultiva® (remifentanil) Vials (Sep. 25 2016)
Fentanyl for Breakthrough Pain (Sep. 22 2016)
Colchicine for Constipation (Sep. 15 2016)
September: Dementia Awareness Month (Sep. 08 2016)
GlucaGen® HypoKit (glucagon) (Sep. 07 2016)
Recall of Lescol® Tablets (fluvastatin) (Sep. 06 2016)
The Confusion with ‘Sulfur allergy’ (Sep. 01 2016)
Recall of APOCabergoline® Tablets (cabergoline) (Sep. 01 2016)
Availability of Zantac® Ampoules (Ranitidine 50mg/2mL) (Aug. 28 2016)
Hepatitis B Reactivation (Aug. 25 2016)
Safety Advisory for Actilyse® Vials (Aug. 25 2016)
Inhaler Devices in the Treatment of COPD and Asthma (Aug. 18 2016)
Armodafinil for Improved Wakefulness (Aug. 11 2016)
Rythmodan 150mg (Disopyramide) Capsules (Aug. 11 2016)
Recall of Colestid®Sachets (colestipol) (Aug. 09 2016)
Chemotherapy-Induced Peripheral Neuropathy (Aug. 04 2016)
Availability of Norfloxacin Tablets (Aug. 02 2016)
Availability of Celestone® Chronodose (betamethasone) Ampoules (Aug. 01 2016)
National Pain Week: July 25-31 2016 (Jul. 28 2016)
Safety Advisory Update for Glyceryl Trinitrate Tablets (Jul. 28 2016)
Gastro-oesophageal Reflux Disease (Jul. 21 2016)
Discontinuation of Arthrotec® 50 Tablets (Jul. 17 2016)
Monoclonal Antibodies for Hypercholesterolaemia (Jul. 14 2016)
Availability of Remifentanil (Jul. 13 2016)
Availability of Ovestin® (oestriol) Cream (Jul. 12 2016)
Adverse Drug Reactions (Jul. 07 2016)
Availability of Hospira™ Cefoxitin 1g Vials (Jul. 07 2016)
Safety Advisory for Bonney’s Blue Surgical Dye (Jul. 06 2016)
Recall of Chlorofluor® Gel (Jul. 05 2016)
Oncolytic Viral Therapy (Jun. 30 2016)
Gastrointestinal Side Effects of Clozapine (Jun. 23 2016)
Naloxegol – Addressing a Common Side Effect of Opioid Therapy (Jun. 16 2016)
Hepatitis C Medications (Jun. 10 2016)
Thyroxine Storage Conditions (Jun. 02 2016)
Safety Advisory for Glyceryl Trinitrate Tablets (Jun. 01 2016)
To Quit or not to Quit (May. 26 2016)
Availability of Bactroban® Ointment (May. 26 2016)
Recall of Zoledasta® Vials (zoledronic acid 5mg/100mL) (May. 23 2016)
Availability of Clomiphene Tablets (May. 22 2016)
PBS Listing Extended for Arsenic Trioxide (May. 19 2016)
Children’s Panadol® Suspension (paracetamol 48mg/mL) (May. 19 2016)
Herbs and Liver Enzymes (May. 12 2016)
Recall of Rifadin® 600mg Vials (May. 09 2016)
Greater Dosing Flexibility for Chronic Pain (May. 05 2016)
Availability of Neulactil® (periciazine) tablets (May. 04 2016)
Infective Endocarditis (Apr. 28 2016)
Recall of DBL™ Vancomycin 500mg (10 vials) (Apr. 26 2016)
A New Indication for Ivermectin (Apr. 21 2016)
Febuxostat in chronic gout (Apr. 14 2016)
Nadroparin Relists on the PBS (Apr. 07 2016)
Recall of Burinex® Tablets (bumetanide 1mg) (Apr. 07 2016)
Olanzapine Depot and Post-Injection Syndrome (Mar. 31 2016)
Zerbaxa™ (ceftolozane/tazobactam) – A New Option for GramNegative Infections (Mar. 23 2016)
Recall of Betamin® Tablets (thiamine 100mg) (Mar. 22 2016)
Availability of Cogentin® Injection (benztropine 2mg/2mL) (Mar. 20 2016)
Influenza: Vaccination Information for 2016 (Mar. 18 2016)
Dymista® 125/50 Nasal Spray Recall (Mar. 17 2016)
Intravenous Fluid Replacement (Mar. 10 2016)
EpiPen® 300µg AutoInjector (Mar. 08 2016)
Infectious Conjunctivitis (Mar. 03 2016)
Recall of Renitec Plus® Tablets (Feb. 29 2016)
Recall of Paracetamol OsteoTab® Bottle Packs (Feb. 28 2016)
Liraglutide Indications Expanded (Feb. 25 2016)
Recall of Nuelin® SR Tablets (theophylline 250mg) (Feb. 21 2016)
Proton Pump Inhibitors and the Elderly – What are the Risks? (Feb. 18 2016)
Recall of OndansetronDRLA® Tablets and Ondansetron SZ® Tablets (Feb. 14 2016)
Update on Pertussis Vaccine Recommendations (Feb. 11 2016)
Recall of Veletri® Consumables Kit (containing water for injections) (Feb. 11 2016)
Fidaxomicin (Dificid®): a new class of antibiotics (Feb. 05 2016)
Recall of Diamox® Tablets (acetazolamide 250mg) (Feb. 01 2016)
Isosorbide Mononitrate – To Halve or Not to Halve (Jan. 28 2016)
Medicinal Cannabis and Legislative Changes (Jan. 21 2016)
Brimica® Genuair® 340/12 (Jan. 13 2016)
Overview of Oral Anticoagulants (Jan. 07 2016)
Availability of Duodart® (dutasteride 500μg and tamsulosin 400μg) capsules (Jan. 03 2016)
Updated Varenicline Product Information (Dec. 30 2015)
Common Eye Diseases of the Elderly (Dec. 23 2015)
Recall of Maxolon® Tablets (metoclopramide 10mg) (Dec. 23 2015)
Immunonutrition – Effect on Length of Stay and Infection Rates (Dec. 17 2015)
2016 HPS Lecture Series Programme (Dec. 16 2015)
The Role of Magnesium in Our Daily Lives (Dec. 10 2015)
Paediatric Analgesia Review (Dec. 03 2015)
A Post-Antimicrobial Era (Nov. 26 2015)
Viekira Pak for Hepatitis C (Nov. 19 2015)
Stepped Approach in Asthma Management (Nov. 12 2015)
Micafungin (Nov. 05 2015)
Zarontin® 250mg Capsules (Nov. 03 2015)
Brentuximab Vedotin (Oct. 29 2015)
Dabigatran Antidote on the Horizon (Oct. 22 2015)
Epilim® EC 200mg Tablets (Oct. 22 2015)
Tapentadol (Oct. 15 2015)
Akynzeo® (Oct. 08 2015)
Availability of Timentin® (Oct. 05 2015)
Bexsero® (Oct. 01 2015)
Neupogen (filgrastim) 480µg Syringes (Sep. 28 2015)
Recall of Ircal® Eye Ointment (Sep. 27 2015)
Middle East Respiratory Syndrome (Sep. 24 2015)
Recall of Serophene (Sep. 22 2015)
Increased Access to HIV Medications in the Community (Sep. 17 2015)
A New Inhalation Device for COPD (Sep. 10 2015)
The Evolution of Biologicals: From Cow Pus To Reverse Aging (Sep. 03 2015)
Becton Dickinson Hypodermic Syringes (Sep. 03 2015)
Recall of APOParacetamol (Sep. 02 2015)
Availability Update: Norfloxacin (Sep. 01 2015)
Recall of Bactroban® Cream (Aug. 31 2015)
Atypical Diabetic Ketoacidosis – SGLT2 Inhibitors (Aug. 27 2015)
Orthostatic Hypotension In The Elderly (Aug. 25 2015)
Availability of Lucrin (leuprorelin acetate) 5mg/mL Injection Multidose Vials (Aug. 16 2015)
Overcoming the Challenges of Opioid Allergies (Aug. 13 2015)
ParaAminosalicylic Acid – What’s Old is New Again (Aug. 13 2015)
Availability of Proctosedyl Ointment (hydrocortisone/cinchocaine) (Aug. 13 2015)
Anticholinergic Drug Burden (Aug. 06 2015)
Availability of Norfloxacin (Aug. 06 2015)
Lurasidone – A New Treatment for Schizophrenia (Jul. 30 2015)
Availability of Hydrozole (Jul. 29 2015)
Treatment and Prevention of Mucositis Secondary to Cancer Treatment (Jul. 23 2015)
Availability of Verapamil (Jul. 21 2015)
Ivabradine (Coralan®) (Jul. 16 2015)
Hypertension Targets for Diabetes Mellitus Patients (Jul. 09 2015)
Stelara – Bringing Relief to Psoriasis Sufferers (Jul. 02 2015)
Bell’s Palsy (Jun. 25 2015)
Safety Alert Update Propofol (Jun. 23 2015)
Methotrexate Precautions Extended (Jun. 18 2015)
Availability of Norfloxacin (Jun. 18 2015)
In A PINCH(S) (Jun. 11 2015)
PBAC Reviews Medicines for Type 2 Diabetes (Jun. 04 2015)
Anticoagulants – A Nurse’s Perspective (May. 28 2015)
Thyroxine Tablets (May. 21 2015)
Suxamethonium Safety Alert (May. 21 2015)
Poor Literacy is a Health Hazard (May. 14 2015)
Safety Alert: Propofol (May. 14 2015)
Availability of Synarel® Nasal Spray (May. 10 2015)
A New Therapy for Gout Febuxostat (May. 07 2015)
Availability of Prostin E2 (dinoprostone) Vaginal Gel (May. 07 2015)
Amoxycillin and Ampicillin Availability (May. 03 2015)
Recall of Methotrexate Tablets (May. 01 2015)
The Long & Winding Road of Anti-inflammatories (Apr. 30 2015)
Potential Disruption to National Supply (Apr. 29 2015)
Availability of Prostin (Apr. 28 2015)
Potential Disruption to National Supply (Apr. 28 2015)
Victoza (liraglutide) (Apr. 23 2015)
Pantoprazole Tablets (Apr. 23 2015)
Australian Pharmacists at World War I (Apr. 23 2015)
Suxamethonium Availability Resolved (Apr. 20 2015)
BCG (Bacillus Calmette – Guerin) Availability (Apr. 19 2015)
Using bioCSL Fluvax® Safely (Apr. 16 2015)
Recall of Curam Duo Forte Tablets (Apr. 16 2015)
Ultibro Breezhaler 100/50 (Apr. 09 2015)
Serotonin Syndrome (Apr. 01 2015)
Purple Day for Epilepsy (Mar. 26 2015)
Managing Motor Complications in Late Stage Parkinson’s Disease (Mar. 24 2015)
Fish Oil or Snake Oil? (Mar. 19 2015)
Drug Safety: The Effect on Drug Metabolism (Mar. 17 2015)
Suxamethonium Availability Update (Mar. 15 2015)
Refrigerated Medicine Stocks (Mar. 12 2015)
Recall of Pfizer Tablet and Capsule Bottles (Mar. 12 2015)
Medication Safety and NSQHS Standards (Mar. 11 2015)
Amiodarone Pneumonitis (Mar. 05 2015)
Suxamethonium Availability (Mar. 05 2015)
The Stigma of Mental Illness (Mar. 01 2015)
Resolving Genetic Hyperammonaemia (Feb. 26 2015)
Xalkori® (crizotinib) (Feb. 26 2015)
Restless Legs Syndrome (Feb. 19 2015)
2015 Influenza Vaccine (Feb. 12 2015)
Tumour Profiling: Way of the Future? (Feb. 05 2015)
Recall of Akineton Tablets (Feb. 05 2015)
NeoMercazole® (carbimazole) Tablets (Feb. 01 2015)
Seebri® Breezhaler® (Glycopyrronium Bromide) (Jan. 29 2015)
Medicines Use in Breastfeeding (Jan. 22 2015)
Fentanyl Intranasal Spray (Jan. 22 2015)
Digoxin Toxicity (Jan. 20 2015)
Cetuximab: Management and Prevention of Cutaneous Side Effects (Jan. 18 2015)
Fixing the leak with Botox® (Jan. 15 2015)
Hydralazine Availability (Jan. 15 2015)
Recall of Jurnista® (Jan. 15 2015)
National Medical Stockpile (Jan. 13 2015)
Thalidomide and Newer Analogues for Multiple Myeloma (Jan. 08 2015)
HPS Celebrates 40 Years of Dose Administration (Jan. 06 2015)
A Rare Form of Cancer (Jan. 01 2015)
Prepare for the Unpredictable (Jan. 01 2015)
Newsline Summer 2015 (Jan. 01 2015)
2015 HPS Lecture Series Programme (Dec. 25 2014)
Adverse Risks Associated with Pregabalin (Dec. 18 2014)
ADT® Booster Vaccine Availability (Dec. 18 2014)
Pharmaceutical Sciences Beyond 2020 (Dec. 16 2014)
Febrile Neutropenia (Dec. 11 2014)
Chloramphenicol Ophthalmic (Dec. 11 2014)
Venous Thromboembolism in Cancer Patients (Dec. 09 2014)
Mitoxantrone Hydrochloride (Dec. 08 2014)
Medicine Names – Sense or Sensibility? (Dec. 07 2014)
Cholic Acid, an Orphan Drug (Dec. 04 2014)
Alkeran Availability (Dec. 04 2014)
Tramadol Mixture (Nov. 27 2014)
Symptoms & Syndromes: Acquired Syphilis (Nov. 25 2014)
NAPS Report Released (Nov. 20 2014)
Antimicrobial Stewardship in Australian Hospitals (Nov. 11 2014)
Ruxolitinib A New Class of Antineoplastic (Nov. 06 2014)
Polio – An International Health Emergency (Nov. 05 2014)
Pharmacists May Be Better Utilised (Oct. 30 2014)
Ovestin Availability (Oct. 27 2014)
Isoprenaline Comes Out From the Cold (Oct. 23 2014)
Recall of Zovirax® (aciclovir) Ophthalmic Ointment (Oct. 23 2014)
Code Stroke: Alteplase, Icatibant and Labetalol (Oct. 22 2014)
Bowel Cancer Screening (Oct. 16 2014)
Ipilimumab for Melanoma Treatment (Oct. 13 2014)
PBS Choices Expanded for HRT (Oct. 09 2014)
A New Interaction for an Anti-Emetic Favourite (Oct. 02 2014)
Recall of Meningococcal Vaccine (Sep. 30 2014)
World Pharmacist Day (Sep. 24 2014)
Dexamethasone Injection Availability (Sep. 23 2014)
Tranexamic Acid – The Results Keep Coming (Sep. 18 2014)
National Stroke Week (Sep. 11 2014)
Bricanyl® Quarantine Update (Sep. 09 2014)
Bricanyl® Quarantine (Sep. 08 2014)
Mirabegron (Betmiga®) for Overactive Bladder (Sep. 04 2014)
Denosumab: Incidence of Osteonecrosis of the Jaw (Aug. 28 2014)
The Effectiveness of Chloramphenicol as Prophylaxis for Wound Infection after Minor Skin Surgery (Aug. 21 2014)
Zolpidem Hangover (Aug. 14 2014)
Recall of Red Back Spider Antivenom (Aug. 12 2014)
Hylo®-Fresh and Hylo-Forte® Eye Drops (Aug. 07 2014)
Medicines in Breastfeeding (Aug. 05 2014)
Breo™ Ellipta® (Jul. 31 2014)
Regional Anaesthesia and Pain Management (Jul. 30 2014)
Potassium Chloride Availability (Jul. 28 2014)
Levodopa/Carbidopa Intestinal Gel (Duodopa®) for the Treatment of Advanced Parkinson’s Disease (Jul. 25 2014)
Update on Treatments for Macular Degeneration (Jul. 22 2014)
Use of Prolia® in Men (Jul. 17 2014)
Olanzapine and its Formulations (Jul. 10 2014)
Atenolol Oral Solution Bottle (Jul. 10 2014)
Propofol Quarantine Lifted (Jul. 07 2014)
Adcetris® (brentuximab vedotin) (Jul. 03 2014)
Synacthen® (tetracosactrin) Availability (Jul. 03 2014)
AdrenalineLink Prefilled Syringes (Jun. 29 2014)
Ferric Carboxymaltose (Ferinject®) (Jun. 26 2014)
Propofol Quarantine Update (Jun. 26 2014)
Accessing Medicines through the Special Access Scheme (Jun. 22 2014)
AHPRA Examinations Measure Professional Pharmacy Standards (Jun. 20 2014)
Duty of Care: Day Surgery (Jun. 20 2014)
Good Medication Orders Get Better Results (Jun. 20 2014)
Community-acquired Pneumonia: Antibiotic Stewardship (Jun. 19 2014)
Irritable Bowel Syndrome: Symptoms, Causes and Treatments (Jun. 19 2014)
Bretaris® Genuair® (aclidinium bromide) Inhalation (Jun. 19 2014)
Recall of Eculizumab Infusion Vial (Jun. 17 2014)
Medications used in Benign Prostatic Hyperplasia (Jun. 12 2014)
Additional Scabies Treatment to be Added to PBS (Jun. 05 2014)
Ferric Carboxymaltose Availability (Jun. 03 2014)
Novel Drug for the Treatment of Hyponatraemia – Tolvaptan (May. 29 2014)
Sapropterin Reduces Hyperphenylalaninemia (May. 22 2014)
How Will The 2014 Budget Impact Healthcare? (May. 15 2014)
Influenza: Have You Considered Vaccination? (May. 08 2014)
Propofol Quarantine Update (May. 04 2014)
Antibiotic Profile: Ciprofloxacin (May. 01 2014)
Recall of Provive (May. 01 2014)
Recall of Xyntha (Apr. 28 2014)
Safety Review of Domperidone (Apr. 24 2014)
Lignocaine Gel Availability (Apr. 22 2014)
Flecainide Injection Availability (Apr. 21 2014)
Bowel Prep Availability (Apr. 21 2014)
Maximising Moxifloxacin (Apr. 17 2014)
Availability of Vecuronium (Apr. 16 2014)
Syntometrine Availability (Apr. 16 2014)
Recall of Canesten 6 Day Cream (Apr. 13 2014)
Black Box Warning for Protos® (Apr. 10 2014)
Management of Warfarin Bleeds (Apr. 03 2014)
Safety Issues of Fentanyl Patches (Mar. 30 2014)
OxyContin® Reformulation (Mar. 27 2014)
Stock Shortage of Priorix (Mar. 27 2014)
Stock Shortage of Fentanyl Lozenges (Mar. 23 2014)
Valdoxan (agomelatine) (Mar. 20 2014)
Emergency Oral Contraceptives May Fail (Mar. 13 2014)
Benzathine Stock Outage (Mar. 13 2014)
Stock Shortage of Timentin (Mar. 10 2014)
International Pharmacy: A Traveller’s Perspective (Mar. 06 2014)
Medication Reconciliation and the NSQHS Standards (Mar. 06 2014)
HPS Leads the Industry with Tall Man Lettering (Mar. 06 2014)
Symptoms & Syndromes: Potassium, Plasma and Drugs (Mar. 04 2014)
Clinical Trials Conducted at Pacific Private (Mar. 04 2014)
Pharmacists to Administer Vaccines in 2014 Influenza Season (Mar. 04 2014)
“Complements” to the English Language (Mar. 04 2014)
Par-ent(er)al Demystified (Mar. 04 2014)
HPS Introduces Tall Man Lettering (Mar. 04 2014)
Parenteral Iron (Mar. 03 2014)
Creating the HPS Lecture Series: A Pharmacist’s Perspective (Mar. 03 2014)
Abiraterone (Zytiga®) for Prostate Cancer (Mar. 03 2014)
Drug Dosing in Obesity (Mar. 03 2014)
Newsline Autumn/Winter 2014 (Mar. 01 2014)
Budesonide for Ulcerative Colitis (Feb. 27 2014)
Imipramine Tablets 10mg and 25mg (Feb. 27 2014)
HPS Pharmacies Help Wound Healing (Feb. 20 2014)
Soft Gel Capsule Choking Hazard (Feb. 20 2014)
Strontium ranelate (Protos®) Under Scrutiny (Feb. 13 2014)
Intravenous Sodium Thiosulfate for the Treatment of Calciphylaxis (Calcific Uraemic Arteriolopathy) (Feb. 06 2014)
Transferring Alprazolam to Schedule 8 (Jan. 30 2014)
Thyroxine Drug Interactions (Jan. 23 2014)
Emend® (aprepitant) 165mg Single Dose (Jan. 16 2014)
Anaphylaxis (Jan. 12 2014)
Tapentadol hydrochloride (Palexia®) SR (Jan. 02 2014)
Newsline Summer 2014 (Jan. 01 2014)
Antimicrobial Stewardship – The Next Step (Dec. 29 2013)
Targin (Dec. 25 2013)
Using N-acetylcysteine in the Treatment of Bipolar Disorders (Dec. 22 2013)
Nicotine Replacement Therapy (Dec. 22 2013)
Management of Chemotherapy Induced Nausea and Vomiting (Dec. 22 2013)
N-acetylcysteine and the Prevention of Contrast-Induced Nephropathy (Dec. 22 2013)
Bevacizumab (Avastin) (Dec. 22 2013)
Hyoscine Injection Availability (Dec. 22 2013)
Ivabradine (Coralan®) now listed on the PBS (Dec. 19 2013)
Stock Shortage of Alfentanil and Fentanyl (Dec. 19 2013)
Cytotoxic Drugs and their Safety Considerations (Dec. 17 2013)
Accreditation in Pharmacies (Dec. 12 2013)
Schedule Negotiations May Be Too Public (Dec. 12 2013)
Pharmacists to “Continue Dispensing” (Dec. 12 2013)
Worldwide medicines shortage (Dec. 12 2013)
Ipilimumab: A Novel Treatment for Melanoma (Dec. 12 2013)
Prostin E2 Gel Availability (Dec. 09 2013)
New Dextropropoxyphene Controls (Dec. 05 2013)
Children’s Panadol Suspension Recall (Dec. 01 2013)
MedsCheck in Hospitals (Nov. 28 2013)
Benztropine 2mg Injection Availability (Nov. 26 2013)
Imipramine Availability (Nov. 26 2013)
Carbimazole Availability Update (Nov. 26 2013)
Sodium Bicarbonate 100mL Availability (Nov. 25 2013)
Children’s Panadol Syringe Recall (Nov. 24 2013)
FreeStyle Lite® Blood Glucose Test Strips (Nov. 24 2013)
Go for Gold in Antibiotic Awareness Week (Nov. 21 2013)
Antibiotic Awareness Week (Nov. 14 2013)
Imigran® (sumatriptan) Injection Syringe (Nov. 12 2013)
PBS Recommends New Diabetes Medicine (Nov. 07 2013)
Newsline Spring/Summer 2013 (Nov. 01 2013)
CKD, eGFR and Cockcroft-Gault (Oct. 31 2013)
Methysergide (Deseril) Discontinued (Oct. 31 2013)
Preparing for Schoolie Emergencies (Oct. 24 2013)
Hospital Admission and Abrupt Smoking Cessation (Oct. 17 2013)
Suicide Ideation during ADHD treatment (Oct. 10 2013)
Sulfur Allergies (Oct. 03 2013)
Caelyx® (doxorubicin liposomal) Availability (Sep. 30 2013)
Dimethyl fumarate funded for MS (Sep. 26 2013)
New Government, New Promises (Sep. 19 2013)
Otodex and Sofradex Unavailable (Sep. 19 2013)
Symptoms & Syndromes: Refresher of Thyroid Disorders (Sep. 19 2013)
Linagliptin – An Incretin-Based Therapy for Type 2 Diabetes Mellitus (Sep. 18 2013)
Rifaximin in Hepatic Encephalopathy (Sep. 18 2013)
Dapagliflozin – A Novel Way to Control Blood Glucose (Sep. 18 2013)
Vaccination Trends in Australia (Sep. 18 2013)
Management of Postoperative Nausea and Vomiting (Sep. 18 2013)
Systemic Antifungals (Sep. 15 2013)
Opportunity Within Challenge (Sep. 15 2013)
Patent vs Free Market (Sep. 15 2013)
Accreditation in Practice (Sep. 15 2013)
How can people access, and die from, synthetic drugs? (Sep. 15 2013)
Intussusception and Rotavirus Vaccine (Sep. 12 2013)
Carbimazole Availability (Sep. 11 2013)
Getting High: An Update In Altitude Medicine (Sep. 05 2013)
Antabuse Unavailable (Sep. 01 2013)
Newsline Spring 2013 (Sep. 01 2013)
Suboxone Tablets Discontinued (Aug. 29 2013)
Sodium Bicarbonate 100mL Availability (Aug. 25 2013)
Pharmacy Caught in the Crossfire (Aug. 22 2013)
Rasagiline for Parkinson’s (Aug. 15 2013)
Abraxane (paclitaxel) 100mg Drug Recall (Aug. 13 2013)
Dabigatran (Pradaxa) – an Overview (Aug. 08 2013)
ACE Inhibitors: A Role in Dementia (Aug. 01 2013)
An Aspect of Mental Illness (Jul. 25 2013)
Febridol Paracetamol Drug Recall (Jul. 25 2013)
Fentanyl Nasal Spray (Jul. 18 2013)
Dry Eye Syndrome (Jul. 11 2013)
PBAC Approves of Melanoma Therapy (Jul. 04 2013)
Symptoms & Syndromes: An Update on Crohn’s Disease (Jul. 02 2013)
Drugs Used in Cardiac Failure (Jul. 01 2013)
Can I Crush It? (Jun. 30 2013)
Sustaining Chemotherapy Services (Jun. 30 2013)
Tribunal supports Di-Gesic and Doloxene (Jun. 30 2013)
Healthcare Demographics Drive Reform (Jun. 30 2013)
A World Without Antibiotics (Jun. 30 2013)
From Compliance to Adherence to Concordance (Jun. 30 2013)
Drugs, Prolonged QT Interval and Torsades de Pointes (Jun. 30 2013)
Perioperative Anticoagulation (Jun. 30 2013)
Symptoms & Syndromes: Heart Failure (Jun. 28 2013)
Ceftriaxone Alphapharm 1g Drug Recall (Jun. 24 2013)
Riluzole for Motor Neurone Disease (Jun. 20 2013)
Diclocil (dicloxacillin sodium) Drug Recall (Jun. 20 2013)
Ambisome (amphotericin B) Drug Recall (Jun. 19 2013)
The Triple Whammy (Jun. 13 2013)
Ethinyloestradiol + Cyproterone Safety Review (Jun. 10 2013)
Mycamine (Jun. 06 2013)
Newsline Winter 2013 (Jun. 01 2013)
Antidepressants General Overview (May. 30 2013)
Cidofovir (VISTIDE) Availability (May. 26 2013)
HPV Vaccine (May. 23 2013)
Xylocaine Ampoule Colour Change (May. 23 2013)
CoaguChek XS INR monitors (May. 16 2013)
Warfarin Education Review (May. 15 2013)
World Lupus Day (May. 09 2013)
Adrenaline Prefilled Syringes (May. 02 2013)
Type 2 Diabetes Mellitus: New focus on individualising Glycaemic targets (May. 01 2013)
Lixisenatide for Type 2 Diabetes (Apr. 25 2013)
International Standardisation of Glycosylated Haemoglobin Level Reporting (Apr. 18 2013)
DBL Sodium Nitroprusside Concentrate Injection 50mg/2mL (Apr. 11 2013)
Medtronic Paradigm Insulin Pumps (Apr. 11 2013)
Electronic Medication Charts: A look at the HealthSMART system (Apr. 03 2013)
Prevention is still better than cure (Mar. 27 2013)
ACE and ARB Combination (Mar. 20 2013)
ADEFIN XL 60 (nifedipine) Package Alert (Mar. 14 2013)
Methoxyflurane the Green Whistle (Mar. 12 2013)
FLUARIX (Influenza) vaccine syringe alert (Mar. 07 2013)
Arsenic trioxide injection (Feb. 27 2013)
Symptoms & Syndromes: Opioid Conversions (Feb. 22 2013)
Treatment of Eye Problems (Feb. 21 2013)
Pharmacological Prophylaxis of Opioid Induced Constipation (Feb. 21 2013)
PBS Safety Net: How it Benefits Patients and Hospitals (Feb. 21 2013)
Regulation of Medicines in Australia (Feb. 21 2013)
Role of Complementary Medicines in Hospital Pharmacy (Feb. 21 2013)
Gentamicin Dosing and Monitoring (Feb. 21 2013)
HPS’ Lecture Series Program 2013 (Feb. 21 2013)
Smoking and Antipsychotics: Drug Interactions (Feb. 21 2013)
Junee Correctional Centre Improves Health (Feb. 21 2013)
Anticoagulants in Atrial Fibrillation Under Review (Feb. 21 2013)
Australasian Clinical Indicator Report (Feb. 21 2013)
HPS Pharmacies now offers MedsCheck (Feb. 21 2013)
Ethinyloestradiol + cyproterone acetate safety review (Feb. 14 2013)
PBS treatment for Melanoma (Jan. 31 2013)
Fentanyl Intranasal Solution Drug Recall (Jan. 28 2013)
Hydroxyurea Availability (Jan. 22 2013)
Melanoma prevention with Sunscreens (Jan. 17 2013)
Morphine Availability Update (Jan. 09 2013)
New simvastatin/sitagliptin combination (Jan. 03 2013)
Newsline Summer 2013 (Jan. 01 2013)
Salbutamol Drug Recall (Dec. 23 2012)
Ivadrabine (CORALAN, Servier Laboratories) (Dec. 20 2012)
SALPRAZ (pantroprazole) Package Alert (Dec. 20 2012)
Minijet Availability (Dec. 13 2012)
Symptoms & Syndromes: New Treatments for Hepatitis C (Dec. 11 2012)
Complementary Medicines in Cardiovascular Disease (Dec. 10 2012)
The Safe Handling of Hazardous Drugs (Dec. 10 2012)
IV to Oral Switch Therapy (Dec. 10 2012)
Ixabepilone in Metastatic Breast Cancer (Dec. 09 2012)
Aseptic and Cytotoxic Training Program at Peter Mac (Dec. 09 2012)
Amoxycillin Challenge (Dec. 09 2012)
Ticagrelor (BRILINTA) (Dec. 06 2012)
Morphine Availability (Nov. 26 2012)
Propranolol Unavailable (Nov. 25 2012)
Ketamine may also treat Depression (Nov. 22 2012)
Carbetocin Availability (Nov. 20 2012)
Timentin Availability (Nov. 20 2012)
Analgesic Agonies (Nov. 08 2012)
Aflibercept (EYELEA) for Macular Degeneration (Oct. 25 2012)
Exforge HCT Availability (Oct. 24 2012)
SIFROL (pramipexole HCI) tablets (Oct. 18 2012)
INFANRIX hexa Vaccine Recall (Oct. 15 2012)
Omalizumab (XOLAIR, Novartis) (Oct. 11 2012)
TYPHIM VI (typhoid) Vaccine Recall (Oct. 04 2012)
Duloxetine Extension to Indications Rejected (For Now) (Sep. 27 2012)
SIFROL (pramipexole HCl) Safety Alert (Sep. 20 2012)
SERENACE (haloperidol) Recall (Sep. 18 2012)
TachoSil for Surgical Haemostasis (Sep. 13 2012)
Campral Availability (Sep. 13 2012)
Timentin Availability (Sep. 13 2012)
Newsline Spring 2012 (Sep. 01 2012)
Mifepristone (RU486) (Aug. 30 2012)
Healthy Bones Diet to Drugs (Aug. 19 2012)
More Information on Adverse Drug Reactions (Aug. 02 2012)
Australian Innovators to Cure the Cold? (Jul. 19 2012)
Actonel EC improves bioavailability (Jul. 05 2012)
Inhalers: Medications, Indications and Devices (Jun. 20 2012)
Newsline Winter 2012 (Jun. 01 2012)
Postoperative Pain Management: Reducing the Evidence – Practice Gap (Mar. 18 2012)
Newsline Autumn Edition 2012 (Mar. 01 2012)
Newsline Summer 2012 (Jan. 01 2012)
